Corebridge Financial (CRBG) Earnings Analysis
Corebridge Financial (CRBG) has no confirmed upcoming earnings date. Last quarter (2026-05-04) it missed with EPS 1.05 USD vs 1.07 USD est (-1.9%). It has beaten estimates in 4/7 recent quarters (57%). Trailing P/E 57.60.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CRBG next report earnings?
No confirmed upcoming earnings date is currently scheduled for CRBG. This page updates as the calendar is published.
CRBG earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-04 | 1.05 USD | 1.07 USD | -1.9% | Miss |
| 2026-02-09 | 1.22 USD | 1.11 USD | +9.9% | Beat |
| 2025-11-03 | 0.96 USD | 1.08 USD | -11.1% | Miss |
| 2025-08-04 | 1.36 USD | 1.14 USD | +19.3% | Beat |
| 2025-05-05 | 1.16 USD | 1.14 USD | +1.8% | Beat |
| 2025-02-12 | 1.23 USD | 1.27 USD | -3.1% | Miss |
| 2024-11-04 | 1.38 USD | 1.17 USD | +17.9% | Beat |
Beat rate: 4/7 (57%) over reported quarters with consensus data.
CRBG valuation and analyst view
| Trailing P/E | 57.60 |
|---|---|
| Trailing EPS | 0.51742 USD |
| Price / book | 1.39 |
| Dividend yield | 3.09% |
| Market cap | 14.21B |
| Analyst consensus | Buy (13 buy / 5 hold / 0 sell) |
| Avg price target | 35.33 USD |
Related research pages
Frequently asked questions
When is Corebridge Financial (CRBG)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for CRBG. This page updates as the calendar is published.
Did CRBG beat earnings last quarter?
In its 2026-05-04 report, CRBG posted EPS of 1.05 USD versus a 1.07 USD estimate — a miss of 1.9%.
What is CRBG's earnings track record?
Over the last 7 reported quarters with consensus data, CRBG beat estimates 4 times (57%).
What is CRBG's current P/E ratio and EPS?
CRBG trades at a trailing P/E of 57.60 on trailing EPS of 0.5174234424498416 USD.
What do analysts rate CRBG?
Analyst consensus is "Buy" across 18 ratings (0 strong buy, 13 buy, 5 hold, 0 sell, 0 strong sell). Average 12-month price target: 35.33 USD.